A AARDVARK THERAPEUTICS Trademark

Trademark Overview


On Sunday, November 17, 2024, a trademark application was filed for A AARDVARK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the A AARDVARK THERAPEUTICS trademark a serial number of 98857689. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, March 24, 2026. This trademark is owned by AARDVARK THERAPEUTICS, INC.. The A AARDVARK THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic pharmaceuticals for the treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; therapeutic pharmaceuticals for cancer treatment and management; abuse-deterrent pharmaceutical preparations for treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity

Medical and scientific research and development in the field of diagnosis and treatment of autism; providing medical and scientific research information in the field of autism; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the field of autism; clinical research in the field of autism
a aardvark therapeutics

General Information


Serial Number98857689
Word MarkA AARDVARK THERAPEUTICS
Filing DateSunday, November 17, 2024
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, March 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 29, 2025

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesTherapeutic pharmaceuticals for the treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; therapeutic pharmaceuticals for cancer treatment and management; abuse-deterrent pharmaceutical preparations for treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity
Goods and ServicesMedical and scientific research and development in the field of diagnosis and treatment of autism; providing medical and scientific research information in the field of autism; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the field of autism; clinical research in the field of autism
Description of MarkThe mark consists of the wording A AARDVARK THERAPEUTICS. The wording AARDVARK THERAPEUTICS appears in lower-case spelling on two lines with a stylized letter capital A to the left of the wording. The horizontal line in the letter A is replaced with a series of nine shaded circles in a curved line.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 17, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAARDVARK THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
US

Party NameAARDVARK THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
US

Trademark Events


Event DateEvent Description
Sunday, November 17, 2024NEW APPLICATION ENTERED
Friday, May 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 9, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, May 12, 2025ASSIGNED TO EXAMINER
Wednesday, May 14, 2025NON-FINAL ACTION WRITTEN
Wednesday, May 14, 2025NON-FINAL ACTION E-MAILED
Wednesday, May 14, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 23, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 29, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 29, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 23, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 23, 2026TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, April 1, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 1, 2026ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Wednesday, April 1, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 23, 2026DIVISIONAL REQUEST RECEIVED
Friday, April 3, 2026RESPONSE TO ITU OFFICE ACTION ENTERED
Friday, April 3, 2026DIVISIONAL PROCESSING COMPLETE
Friday, April 3, 2026CORRECTED NOA E-MAILED
Friday, April 3, 2026ABANDONMENT - NO USE STATEMENT FILED
Friday, April 3, 2026ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED